05 December 2021
: Case report 
Efficacy of Systemic Acyclovir as Adjuvant Therapy for Oral Lichen Planus
Unusual setting of medical care
Dewi Zakiawati12ABCDEF*, Muhammad Al Farisyi1ABCDF, Tenny Setiani Dewi2ACDEFDOI: 10.12659/AJCR.934554
Am J Case Rep 2021; 22:e934554
Table 1. Laboratory findings.
| Test | Results | Reference value | Unit | |
|---|---|---|---|---|
| First visit | Third control | |||
| Hemoglobin | 11.1 | 9.9 | 14.0–17.4 | g/dL |
| Erythrocyte | 3.6 | 3.65 | 4.4–6 | 10/µl |
| Hematocrit | 32.2 | 30.6 | 41.5–50.4 | % |
| MCV | 89.4 | 83.8 | 80–96 | fL |
| MCH | 30.8 | 27.1 | 27.5–33.2 | Pg |
| MCHC | 34.5 | 32.4 | 33.4–35.5 | % |
| RDW-CV | – | 14.9 | 11.5–14.5 | % |
| RDW-SD | – | 45 | 35.1–43.9 | fL |
| Leucocyte | 4720 | 3880 | 4400–11 300 | /µl |
| Thrombocyte | 105 000 | 91 000 | 150 000–450 000 | /µl |
| SGOT (AST) | 84 | 71 | 15–37 | U/L |
| SGPT (ALT) | 74 | 61 | 16–73 | U/L |
| ESR | – | 29 | <15 | mm/hour |
| PT | – | 14.3 | 11–15 | second |
| INR | – | 1.03 | 0.8–1.2 | – |
| APTT | – | 29.7 | 21–41 | second |
| TIBC | – | 373 | 250–450 | µ/dL |
| HbA1c | 6.3 | 7.8 | 4.5–6.2 | % |
| IgG anti-HSV-1 | – | >34.8 | Negative <9Borderline: 9–11Positive >11 | U/mL |
| MCV – mean corpuscular volume; MCH – mean corpuscular hemoglobin; MCHC – mean corpuscular hemoglobin concentration; RDW-CV – red cell distribution width coefficient of variation; RDW-SD – red cell distribution width standard deviation; SGOT/AST – serum glutamic oxaloacetic transaminase/aspartate aminotransferase; SGPT/ALT – serum glutamic pyruvate transaminase/alanine aminotransferase; ESR – erythrocyte sedimentation rate; PT – prothrombin time; INR – international normalizing ratio; APTT – activated partial thromboplastin time; TIBC – total iron-binding capacity; HbA1c – hemoglobin A1c; IgG HSV-1 – immunoglobulin G for herpes simplex virus-1, – low, H – high, HH – very high. | ||||